These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9009661)

  • 41. [Case of chronic necrotizing pulmonary aspergillosis successfully treated with a combination of liposomal amphotericin B and itraconazole].
    Kiyokawa H; Nakashima R; Takafuji S; Suzuki Y; Ito A
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):448-54. PubMed ID: 18592989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Aspergillosis in pulmonary transplantation].
    de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolated kidney localization of invasive Aspergillosis in a patient with AIDS.
    Viale P; Di Matteo A; Sisti M; Voltolini F; Paties C; Alberici F
    Scand J Infect Dis; 1994; 26(6):767-70. PubMed ID: 7747106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Invasive infection by Aspergillus terreus treated successfully with liposomal amphotericin B].
    Suárez Ortega S; Campos-Herrero Navas MI; Limeres González MA; Díaz López F; Zarzalejos Andes JM; Arkuch Saade ME
    An Med Interna; 2004 Jan; 21(1):20-2. PubMed ID: 15195481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pulmonary zygomycosis in a patient treated for invasive aspergillosis].
    Tricot S; Gastine T; Sendid B; Wurtz A; de Botton S; Alfandari S
    Med Mal Infect; 2006 Feb; 36(2):118-21. PubMed ID: 16458464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal susceptibility of Aspergillus species isolated from invasive oral infection in neutropenic patients with hematologic malignancies.
    Myoken Y; Sugata T; Myoken Y; Kyo T; Fujihara M; Mikami Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Feb; 87(2):174-9. PubMed ID: 10052372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Curative antifungal treatment of invasive pulmonary aspergillosis].
    Andrès E; Courouau F; Kurtz JE; Limacher JM; Quoix E
    Rev Pneumol Clin; 1995; 51(4):228-31. PubMed ID: 7501940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of direct infusion of antifungal agent on invasive pulmonary aspergillosis in a patient with acute leukemia.
    Nakase K; Yazaki A; Tamaki S; Tanigawa M; Tsuji K; Miyanishi E; Shiku H
    J Infect Chemother; 2002 Mar; 8(1):106-8. PubMed ID: 11957130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spontaneous reversibility of "pleural thickening" in a patient with semi-invasive pulmonary aspergillosis: radiographic and CT findings.
    Franquet T; Giménez A; Cremades R; Domingo P; Plaza V
    Eur Radiol; 2000; 10(5):722-4. PubMed ID: 10823622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Itraconazole in neutropenic patients.
    van't Wout JW
    Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study.
    Kartsonis NA; Saah AJ; Joy Lipka C; Taylor AF; Sable CA
    J Infect; 2005 Apr; 50(3):196-205. PubMed ID: 15780413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tibial osteomyelitis due to Aspergillus flavus in a heart transplant patient.
    De Vuyst D; Surmont I; Verhaegen J; Vanhaecke J
    Infection; 1992; 20(1):48-9. PubMed ID: 1314228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Aspergillosis in acquired immunodeficiency syndrome].
    Meyohas MC; Roux P; Poirot JL; Meynard JL; Frottier J
    Pathol Biol (Paris); 1994 Sep; 42(7):647-51. PubMed ID: 7877856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of tongue aspergillosis caused by Aspergillus flavus with liposomal amphotericin B in a child with acute lymphoblastic leukemia.
    Bor O; Cagri Dinleyici E; Kiraz N; Dundar E; Akdeniz Akgun N
    Med Mycol; 2006 Dec; 44(8):767-70. PubMed ID: 17127634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Itraconazole therapy for primary cutaneous aspergillosis in patients with AIDS.
    van Burik JA; Colven R; Spach DH
    Clin Infect Dis; 1998 Sep; 27(3):643-4. PubMed ID: 9770169
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapeutic outcome in invasive aspergillosis.
    Denning DW
    Clin Infect Dis; 1996 Sep; 23(3):608-15. PubMed ID: 8879787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis.
    Patterson TF; Fothergill AW; Rinaldi MG
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2307-10. PubMed ID: 8285610
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
    Silvanose CD; Bailey TA; Di Somma A
    Vet Rec; 2006 Aug; 159(9):282-4. PubMed ID: 16946311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.
    Steinbach WJ; Stevens DA; Denning DW
    Clin Infect Dis; 2003 Oct; 37 Suppl 3():S188-224. PubMed ID: 12975752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Two cases of pulmonary aspergillosis successfully treated with multidrug therapy].
    Anndo T
    Jpn J Antibiot; 2000 Feb; 53(2):84-90; dicussion 90. PubMed ID: 10896540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.